IP Verse

Lepthien patent opposition analysis

The comprehensive analysis of Lepthien opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Lepthien

Stay updated with the latest patent oppositions filed by Lepthien

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3487881
Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTISMay 21, 2025GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
EP2854831
Manufacture Of DegarelixFERRINGApr 10, 2025GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
EP3529360
Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionTHE MEDICINESJan 17, 2025GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
EP3191120
Use Of Il-17 Antagonists To Inhibit The Progression Of Structural Damage In Psoriatic Arthritis PatientsNOVARTISJan 10, 2025GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
EP3328416
Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal DysplasiaBIOMARIN PHARMACEUTICALDec 13, 2024GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
EP3334747
Charged Depth Filtration Of Antigen-Binding ProteinsAMGENJun 27, 2024GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
EP3445850
Methods For Providing Single-Stranded RnaBIONTECHJul 27, 2022LDS LAZEWSKI DEPO & PARTNERS

Top clients of Lepthien

Top companies who are the clients of Lepthien

CompanyTotal
GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT8
LDS LAZEWSKI DEPO & PARTNERS1